Articles

Brett Arends's ROI: Why Bud Light brewer AB InBev isn’t an investment slam dunk — yet

This is a buying opportunity that ought to unite progressives and conservatives

Your Digital Self: Coinbase and Binance crackdown hurts the U.S. more than it does bitcoin and other crypto

While regulators aim to keep Americans from crypto, the industry is thriving, writes Jurica Dujmovic.

Financial Crime: Heads of ‘orgasmic meditation’ group, OneTaste, charged with forced labor and sex abuse of followers

The group’s founder, Nicole Daedone, promised enlightenment through orgasms, but prosecutors say she ran a cult-like operation.

Market Extra: Small-cap stocks surge as broader U.S. market stalls. Here’s why.

The small-cap Russell 2000 index surges Tuesday. Is it time to play catch-up with megacap tech stocks?

: The headset face-off: How Apple’s Vision Pro compares with the Meta Quest Pro, beyond a huge price gap

Apple splashed into the world of mixed reality this week with its new Vision Pro headset, joining Meta and others in the quest to turn VR headsets cool.

: Merck is suing the government over Medicare drug prices—what retirees need to know

Inflation Reduction Act provision was set to lower drug costs for millions of retirees

The Fed: Former Kansas City Fed chief calls inflation ‘sticky’ and says interest rates will stay high

Recently retired Kansas City Fed President Esther George said the U.S. is likely to "have higher inflation and higher interest rates for some time."

: Stitch Fix stock rallies as results beat, and company takes further steps to pare back

Shares of Stitch Fix Inc. rose after hours after the online clothing-selection and styling service reported better-than-expected third-quarter results.

The Tell: Big Tech bulks up in S&P 500 in 2023 outweighing index’s energy sector, DataTrek says

Big Tech’s market value in the S&P 500 has surged to more than a quarter of the index, with just seven stocks this year adding heft larger than the weight of its entire energy sector, according to DataTrek Research.

: Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say

Pharmaceutical giant says it's prepared to take case to the Supreme Court as it seeks to sidestep negotiation program

: Want to live in these 11 cities? You’ll need to make at least $100,000 to avoid being ‘rent burdened,’ researchers say.

New rental data "perfectly" illustrates the housing-affordability crisis, an economist says.

The Ratings Game: Bud Light boycott is helping one of the beer’s main rivals, analysts say

The boycott of Bud Light over its partnership with a trans influencer has endured long enough to help one of its main rivals, BofA analysts said.
1 1,689 1,690 1,691 1,692 1,693 1,699